The Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) to Applied Therapeutics regarding the New Drug Application (NDA) for govorestat for the treatment of classic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback